期刊文献+

Synthesis and Crystal Structure of a Luminescent Compound 5-(1H-benzoimidazol-2-yl)-3H-[1,2,3]triazole-4-carboxylic Acid

Synthesis and Crystal Structure of a Luminescent Compound 5-(1H-benzoimidazol-2-yl)-3H-[1,2,3]triazole-4-carboxylic Acid
在线阅读 下载PDF
导出
摘要 The title compound, 5-(1H-benzoimidazol-2-yl)-3H-[1,2,3]triazole-4-carboxylic acid (CIoH.7Ns.O2.C3H7NO, M,..= 302.30), has been synthesized and characterized by FT-IR and ES1-MS, ~H-NMR spectroscopy and X-ray single-crystal diffraction. Crystal structure of the title compound was grown from DMF by slow diffusion at room temperature. Crystal data: orthorhombic structure, space group Pna2+ with a = 6.9635(3), b = 19.4398(7), c = 30.6165(12) A, V = 4144.5(3) A3, Z = 12, Dc = 1.454 g/cm3,/l(MoKa) = 0.108 mm-1, and F(000) = 1896. The structure was refined to R = 0.0450 and wR = 0.0975 for 3578 observed reflections with 1 〉 2σ(I). The interm01ecular hydrogen bonds and π-π stacking further stabilize the structure. The title compound, 5-(1H-benzoimidazol-2-yl)-3H-[1,2,3]triazole-4-carboxylic acid (CIoH.7Ns.O2.C3H7NO, M,..= 302.30), has been synthesized and characterized by FT-IR and ES1-MS, ~H-NMR spectroscopy and X-ray single-crystal diffraction. Crystal structure of the title compound was grown from DMF by slow diffusion at room temperature. Crystal data: orthorhombic structure, space group Pna2+ with a = 6.9635(3), b = 19.4398(7), c = 30.6165(12) A, V = 4144.5(3) A3, Z = 12, Dc = 1.454 g/cm3,/l(MoKa) = 0.108 mm-1, and F(000) = 1896. The structure was refined to R = 0.0450 and wR = 0.0975 for 3578 observed reflections with 1 〉 2σ(I). The interm01ecular hydrogen bonds and π-π stacking further stabilize the structure.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2012年第11期1662-1668,共7页 结构化学(英文)
基金 Supported by NNSFC(No.91022015)
关键词 benzimidazole derivatives crystal structure ESI-MS fluorescence ESIPT benzimidazole derivatives, crystal structure, ESI-MS, fluorescence, ESIPT
  • 相关文献

参考文献19

  • 1Amuntini, D.; Fringuelli, F.; Piermatti, O.; Pizzo, F.; Zunino, E.; Vaecaro, L. Synthesis of 4-aryl- 1 H- 1,2,3 -triazoles through TBAF-catalyzed [3 +2 ] cycloaddition of 2-aryl-1-nitroethenes with TMSN3 under solvent-free conditions. J. Org. Chem. 2005, 70, 6526-6529.
  • 2Cai, D. W.; Joumet, M.; Larsen, R. D. Linear process for the preparation of a morpholine compound. US 6051707[P] 2000-4-18.
  • 3Genin, M. J.; Allwine, D. A, ; Anderson, D. J.; Barbachyn, M, K,; Emmert, D. E,; Garmon, S. A.; Graber, D. R.; Grega, K. C,; Hester, J, B.; Hutchinson, D. K.; Morris, J.; Reischer, R. J.; Ford, C. W.; Zurenko, G. E.; Hamel, J. C.; Schaadt, R. D.; Stapert, D.; Yagi, B. H. Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms haemophilus influenzae and moraxena catarrhalis..J. Med. Chem. 2000, 43,953-970.
  • 4Alvarcz, R.; Velazquez, S.; San-Felix, A.; Aquaro, S.; De Clercq, E.; Perno, C. F.; Karlsson, A.; Balzarmi, J.; Camarasa, M. 1,2,3-1riazole- 2.5-bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-anain-l2''-oxathiole 2",2"-dioxide) (TSAO) analogs: synthesis and anli-HIV-1 activity. J. Med. Chem. 1994, 37, 4185-4194.
  • 5Velaquez, S.; Alvarez, R.; Perez, C.; Gago, F.; De Clercq, E.; Balzarini, J.; Camarasa, M. J. Regiospecific synthesis and anti-human immuno-deficiency vin~s activity of novel 5-substituted N-alkylcarbamoyl and N,N-dialkyl carbamoyl 1,2,3-triazole-TSAO analogues anti-human. Antiviral Chem. Chemother. 1995, 9, 481-489.
  • 6S akai, T.; Hamada, T.; Avat, N.; Watanabe, J. Pharmacokinctics of an antiallergic agent, 1 -(2-ethoxyethyl)-2-(hexahydro-4-methyl- 1 H- I, 4-diazepin-l-yl)-I H-benzimidazole difumarate (KG-2413 ) after oral administration: inlerspccies differences in rats, guhlca pigs told dogs. J. Pharmacbio. Dyn. 1989, 12, 530-535.
  • 7Poeta, M. D.; Schell, W. A.; Dykstra, C. C.; Jones, S.; Tidwell, R. R.; Czamy, A.; Bajic, M.; Kumar, A.; Boykin, D.; Perfect, J. R. Structure-in vitro activity relationships of pentamidine analogues and dication-dubstituted bis-benzimidazoles as new anfifungal agents. Antimicrob. Agents Chemother. 1998, 42, 2495-2502.
  • 8Roderick, W. R.; Nordeen, C. W.; Von Esch, A. M.; Appell, R. N. Bisbelmimidazoles. potent inhibitors of rhinoviruses. .J. Med. Chem. 1972, 15,655-658.
  • 9Geratz, J. D.; Tidwell, R. R.; Lombardy, R. J.; Schwab, J. H.; Anderle, S. K.; Pryzwansky, K. B. Streptococcal cell wall-induced systemic disease. Beneficial effects oftrans-bis(5-amidino-2-benzimidazolyl)elhene, a novel, macrophage-directed anti-inflammatory agent. Am. J. Pathol. 1991, 139, 921-931.
  • 10Zeng, M. H.; Yao, M. X.; Liang, H.; Zhang, W. X.; Chen, X. M. A single-molecule-magnetic, cubane-based, triangular Co12 supercluster. Angew: Chem. lnt. Ed. 2007, 46, 1832-1835.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部